These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22642387)

  • 1. Technetium-99m -- new production and processing strategies to provide adequate levels for SPECT imaging.
    Osso JA; Catanoso MF; Barrio G; Brambilla TP; Teodoro R; Dias CR; Suzuki KN
    Curr Radiopharm; 2012 Jul; 5(3):178-86. PubMed ID: 22642387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future of low specific activity molybdenum-99/technetium-99m generator.
    Mushtaq A
    Curr Radiopharm; 2012 Oct; 5(4):325-8. PubMed ID: 22642420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking America's dependence on imported molybdenum.
    Einstein AJ
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):369-71. PubMed ID: 19356583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Technetium crisis" -  causes, possible solutions and consequences for planar scintigraphy and SPECT diagnostics].
    Adam J; Kadeřávek J; Kužel F; Vašina J; Rehák Z
    Klin Onkol; 2014; 27 Suppl 1():S137-42. PubMed ID: 24945551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14 MeV Neutrons for
    Capogni M; Pietropaolo A; Quintieri L; Angelone M; Boschi A; Capone M; Cherubini N; De Felice P; Dodaro A; Duatti A; Fazio A; Loreti S; Martini P; Pagano G; Pasquali M; Pillon M; Uccelli L; Pizzuto A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30060449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Ways to Address Shortage Situations of
    Filzen LM; Ellingson LR; Paulsen AM; Hung JC
    J Nucl Med Technol; 2017 Mar; 45(1):1-5. PubMed ID: 28154015
    [No Abstract]   [Full Text] [Related]  

  • 7. Short- and long-term responses to molybdenum-99 shortages in nuclear medicine.
    Ballinger JR
    Br J Radiol; 2010 Nov; 83(995):899-901. PubMed ID: 20965898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questionnaire survey of hospitals in Saitama Prefecture regarding the shortage of 99mTc-labeled radiopharmaceuticals and 99Mo/99mTc generators.
    Kosuda S; Tomita H; Hayashi K; Kita T; Koike K; Arai T
    Ann Nucl Med; 2010 May; 24(4):319-23. PubMed ID: 20204551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)Tc.
    Cutler CS; Schwarz SW
    J Nucl Med; 2014 Jul; 55(7):1208-13. PubMed ID: 24854794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative isotope sources.
    Kondro W
    CMAJ; 2009 Jan; 180(2):162-3. PubMed ID: 19153388
    [No Abstract]   [Full Text] [Related]  

  • 11. [Technetium-99m production for use in nuclear medicine].
    Vucina J
    Med Pregl; 2000; 53(11-12):631-4. PubMed ID: 11320753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of rat SPECT images obtained using (99m)Tc derived from 99Mo produced by an electron accelerator with that from a reactor.
    Galea R; Wells RG; Ross CK; Lockwood J; Moore K; Harvey JT; Isensee GH
    Phys Med Biol; 2013 May; 58(9):2737-50. PubMed ID: 23552053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fission-Produced
    Youker AJ; Chemerisov SD; Tkac P; Kalensky M; Heltemes TA; Rotsch DA; Vandegrift GF; Krebs JF; Makarashvili V; Stepinski DC
    J Nucl Med; 2017 Mar; 58(3):514-517. PubMed ID: 27688474
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained availability of 99mTc: possible paths forward.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future supply of molybdenum-99.
    Rojas-Burke J
    J Nucl Med; 1995 Nov; 36(11):15N, 22N, 35N. PubMed ID: 7472576
    [No Abstract]   [Full Text] [Related]  

  • 17. In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.
    Martini P; Boschi A; Cicoria G; Zagni F; Corazza A; Uccelli L; Pasquali M; Pupillo G; Marengo M; Loriggiola M; Skliarova H; Mou L; Cisternino S; Carturan S; Melendez-Alafort L; Uzunov NM; Bello M; Alvarez CR; Esposito J; Duatti A
    Appl Radiat Isot; 2018 Sep; 139():325-331. PubMed ID: 29936404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
    Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
    Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molybdenum-99/technetium-99m management: race against time.
    Ahmad M
    Ann Nucl Med; 2011 Nov; 25(9):677-9. PubMed ID: 21728046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making optimal use of available molybdenum-99.
    Ballinger JR
    Nucl Med Commun; 2010 Oct; 31(10):841-3. PubMed ID: 20805729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.